Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Alex Hodge

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Molecular Oncology|November 10, 2016
A pilot study exploring the molecular architecture of the tumor microenvironment in human prostate cancer using laser capture microdissection and reverse phase protein microarrayElisa Pin, Steven Stratton, Claudio Belluco, et al.
Oncotarget|November 16, 2017
Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot studyVienna Ludovini, Rita Chiari, Lorenzo Tomassoni, et al.
British Journal of Cancer|July 1, 2017
Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancersMaria Isabella Sereni, Elisa Baldelli, Guido Gambara, et al.
NPJ Precision Oncology|February 16, 2023
AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancersMaysa M Abu-Khalaf, K Alex Hodge, Christos Hatzis, et al.
Pancreas|July 4, 2019
Endogenous Gastrin Collaborates With Mutant KRAS in Pancreatic CarcinogenesisSandeep Nadella, Julian Burks, Matthew Huber, et al.
Medrxiv : the Preprint Server for Health Sciences|August 9, 2020
Clinical Utility of a Highly Sensitive Lateral Flow Immunoassay as determined by Titer Analysis for the Detection of anti-SARS-CoV-2 Antibodies at the Point-of-CareAmanda Haymond, Claudius Mueller, Hannah Steinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2017
Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast CancerMariaelena Pierobon, Corinne Ramos, Shukmei Wong, et al.
Journal for Immunotherapy of Cancer|October 8, 2021
PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicineElisa Baldelli, K Alex Hodge, Guido Bellezza, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Molecular Oncology|November 10, 2016
A pilot study exploring the molecular architecture of the tumor microenvironment in human prostate cancer using laser capture microdissection and reverse phase protein microarrayElisa Pin, Steven Stratton, Claudio Belluco, et al.
Oncotarget|November 16, 2017
Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot studyVienna Ludovini, Rita Chiari, Lorenzo Tomassoni, et al.
British Journal of Cancer|July 1, 2017
Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancersMaria Isabella Sereni, Elisa Baldelli, Guido Gambara, et al.
NPJ Precision Oncology|February 16, 2023
AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancersMaysa M Abu-Khalaf, K Alex Hodge, Christos Hatzis, et al.
Pancreas|July 4, 2019
Endogenous Gastrin Collaborates With Mutant KRAS in Pancreatic CarcinogenesisSandeep Nadella, Julian Burks, Matthew Huber, et al.
Medrxiv : the Preprint Server for Health Sciences|August 9, 2020
Clinical Utility of a Highly Sensitive Lateral Flow Immunoassay as determined by Titer Analysis for the Detection of anti-SARS-CoV-2 Antibodies at the Point-of-CareAmanda Haymond, Claudius Mueller, Hannah Steinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2017
Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast CancerMariaelena Pierobon, Corinne Ramos, Shukmei Wong, et al.
Journal for Immunotherapy of Cancer|October 8, 2021
PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicineElisa Baldelli, K Alex Hodge, Guido Bellezza, et al.
Pageof 1